Login / Signup

Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes.

Signe SchmidtChristian S FrandsenThomas Fremming DejgaardDorte VistisenThórhallur HalldórssonSjudur F OlsenJens-Erik B JensenSten MadsbadHenrik U AndersenKirsten Nørgaard
Published in: Diabetes, obesity & metabolism (2021)
Liraglutide lowered fat and lean body mass compared with placebo. Further, liraglutide reduced intake of added sugars. However, no significant difference in total daily energy intake was detected between liraglutide- and placebo-treated participants.
Keyphrases